{"id":"W2046879146","doi":"10.1016/j.pharmthera.2012.03.005","title":"Novel therapeutic agents for lowering low density lipoprotein cholesterol","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"","keywords":"Kexin; PCSK9; Proprotein convertase; Tolerability; Pharmacology; Microsomal triglyceride transfer protein; Residual risk; Medicine; Apolipoprotein B; Apolipoprotein C2; Lipoprotein; Drug; Cholesterol; Endocrinology; LDL receptor; Internal medicine; Very low-density lipoprotein; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001191856,0.0009374399,0.003102924,0.0002633075,0.0002648211,0.00003906149,0.0004361189,0.0009315718,0.0001661131],"category_scores_gemma":[0.000004820538,0.0007600244,0.001979001,0.0003206817,0.0001651551,0.0001001073,0.0001510434,0.001219864,0.0001476409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004844704,"about_ca_system_score_gemma":0.000650021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004862152,"about_ca_topic_score_gemma":0.000008048981,"domain_scores_codex":[0.9962385,0.000242681,0.000951635,0.0008114044,0.0005169011,0.001238919],"domain_scores_gemma":[0.9976912,0.0001637092,0.0005199272,0.0009591586,0.0002244573,0.0004415862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001102263,0.0006372825,0.000006124176,0.02144323,0.006793941,0.00001435762,0.00008882862,5.952875e-7,0.0004087352,0.000009278571,0.0000785884,0.9704088],"study_design_scores_gemma":[0.002889967,0.0002731672,0.00007042023,0.002000885,0.03225595,0.0005711651,0.000007867306,0.00002952343,0.0006879703,0.000009170423,0.9606027,0.0006011904],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002083113,0.9816884,0.007129574,0.0002606109,0.00254597,0.007813487,0.00008011304,0.0001846789,0.00008880364],"genre_scores_gemma":[0.0008974503,0.9841052,0.0006132088,0.008156701,0.003596028,0.001618026,0.0001601059,0.0003193362,0.0005339471],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9698076,"threshold_uncertainty_score":0.9994851,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1494625961508391,"score_gpt":0.4072496941400489,"score_spread":0.2577870979892097,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}